<DOC>
	<DOCNO>NCT01434147</DOCNO>
	<brief_summary>Phase II pilot study preoperative induction chemotherapy combination Bevacizumab follow combined radiochemotherapy patient locally advanced rectal carcinoma</brief_summary>
	<brief_title>Preoperative Combined Induction Chemotherapy With Capecitabine , Oxaliplatin , Bevacizumab Radiotherapy</brief_title>
	<detailed_description>Induction chemotherapy combine Radio chemotherapy : Therapy start : within 28 day bioptical diagnosis capecitabine 1000 mg/m2 bid 14 day ( d1-d14 ) , oxaliplatin 130 mg/m2 bevacizumab 7.5 mg/kg body weight d1 ; repetition day 22 43 ( 3 cycle ) Combined Radiochemotherapy 1 week conclude 3rd cycle induction chemotherapy : Radiotherapy : 5 x 5 day 1.8 Gy ; cumulative dose 45 Gy Chemotherapy : capecitabine 825mg/m² bid , radiation day first 4 week RCTx Surgery accord TME-criteria ( total mesorectal excision ) compliance interruption min . 14 day RCTx</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Age 1880 year Histologic confirmation rectal adenocarcinoma stage cT3 ( ≤ 5mm mesorectal fascia ) /cT4 ( primary curative intention ) NxM0 No former chemotherapy , former radiotherapy pelvic , former tumour resection rectal carcinoma General condition WHO grade 02 Adequate bone marrow reserve ( leucocytes ≥3 000/μl , thrombocytes ≥100 000/μl ) Adequate renal function ( creatinine ≤ 1,5 mg/dl , creatinine clearance &gt; 50ml/min ( Cockcroft Gault formula ) ) Adequate liver function ( bilirubin ≤1,5x ULN , GOT GPT ≤3,5xULN ) Exclusion pregnancy woman childbearing potential ( negative pregnancy test urine serum ) Female patient childbearing potential male patient surgically sterile must practice medically acceptable contraceptive regimen study treatment 3 month end study ( e.g . oral contraceptive , condom , intrauterine device ) Life expectancy least 3 month INR aPTT ≤ 1,5 x LLN Provision sign informed consent registration Rectal carcinoma stage cT3 ( &gt; 5mm mesorectal fascia ) stag &lt; cT3 , M1 Other malignant tumour within last 5 year except cervical carcinoma situ basal cell carcinoma skin General contraindication know hypersensitivity Bevacizumab , Capecitabine Oxaliplatin Not malignant disease treatment radiotherapy , resection rectum treatment chemotherapy ( Bevacizumab , Capecitabine ) contraindicate : uncontrolled hypertension ( systolic &gt; 150 mmHG and/or diastolic &gt; 100 mmHG ) clinically significant ( e.g . active ) cardiovascular disease : CVA ( cardiovascular accident ) / apoplectic insult ( ≤ 6 month prior registration ) , myocardial infarction ( ≤ 6 month prior registration ) , unstable angina pectoris , CHF ( congestive heart failure ) NYHA ( New York heart Association ) Grade II high , cardiac arrhythmia require therapy , hepatic disease , significant neurologic psychiatric disorder Florid , serious infection registration Peripheral neuropathy ( NCI CTCAE v 4.0 ≥ grade 1 ) Juridically limited contractual capability , indication neurological psychiatric disease constrain upon investigator opinion patient capability adhere study routine Major surgical procedure within 28 day prior start study , open wound Significant traumatic injury , bone fracture , unhealed wound Patients spinal cord compression metastases central nervous system Indication bleed diathesis coagulopathy Intake anticoagulant thrombolytic agent and/or Aspirin &gt; 325 mg/d within 10 day prior registration Current recent ( within 10 day prior treatment start ) therapy full dose anticoagulant . Preventive therapy allow . Previous thromboembolic haemorrhagic event within 6 month prior registration Previous abdominal fistula , gastrointestinal perforation intrabdominal abscess within 6 month prior registration Treatment another investigational drug within 28 day prior registration Patients malabsorption syndrome difficulty swallow Indication poor compliance patient Pregnant breastfeed woman Proteinuria : Dipstick &lt; 2+ . If Dipstick ≥2+ protein estimate 24 hour urine . The value high 1g/24 hour .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>locally advanced rectal cancer</keyword>
	<keyword>preoperative induction chemotherapy chemoradiotherapy</keyword>
</DOC>